Report Scope & Overview:
The Pancreatic and Biliary Stents Market Size were expected to grow at a CAGR of 6.8% over the forecast period 2023-2030.
Endoscopic stenting has been demonstrated to be an effective treatment for a variety of pancreaticobiliary disorders. This includes treating biliopancreatic leaks and preventing pancreatitis after endoscopic retrograde cholangiopancreatography (ERCP). The market for endoscopic stenting has benefited from ongoing developments in therapeutic endoscopy, particularly in terms of device design and insertion procedures. Several developments in pancreatic and biliary stent technology have allowed clinicians to provide lumen-to-lumen anchorage and minimize bilia-pancreatic leakages. In the pancreatic and biliary stents market, lumen-apposing metal stents have gained traction for treating both malignant and benign disorders.
To get more information on Pancreatic and Biliary Stents Market - Request Sample Report
Pancreatic and biliary stents are a relatively recent interventional therapeutic option for pancreatic cancer. Palliative stent therapy is rapidly changing its paradigm. Just about all the palliative care involves the use of self-expanding metal stents in this regard. Pancreatic ductal stent insertion is becoming increasingly popular among individuals with chronic pancreatitis. Endoscopists have been updating their skills with novel endosonography techniques and self-expanding metal stents in order to broaden the range of pancreatic and biliary stent applications in recent years.
Prevalence has increased.
Endosonography and self-expanding metal stents (SEMS) are becoming more well-known.
The stent industry is boosted by the use of a minimally invasive transpapillary technique.
Concerns about the high expense of navigating procedural complexities
Government Regulations are Strict
A thorough examination of the company
IMPACT OF COVID-19
The COVID-19 pandemic had a detrimental influence on the biliary stents industry because it affected the global healthcare system, creating considerable delays in surgeries, treatment, and diagnosis of non-emergency medical problems. Several municipal and national regulatory organisations instituted lockdowns, prohibiting the movement of persons and products, as the number of COVID-19 instances increased. The mandated lockdowns had a significant impact on the company's operations, as well as the whole market's supply chain, resulting in delayed and limited biliary stent supply to end users.
In the early months of the COVID-19 pandemic, the considerable effect of the pandemic on product distribution is predicted to have impeded industry expansion and led to a drop in bile duct cancer care. A relationship was also identified in some cases between coronavirus infection and a significant consequence of liver injury. Once a result, as the limits are relaxed, it is expected to have a positive impact on the global market.
By Product Type:
Metal stents and polymer stents are the two types of stents on the market. Metal stents accounted for about 65% of the market in 2021 and are predicted to grow at a healthy pace during the forecast period. Metal stents are mesh-like tubes made up of thin wires that come in a wide range of diameters and lengths. The post-expansion diameter of the self-expandable metal stents ranges from 5 to 10 mm. The increased incidence of bile duct-related disorders like biliary leakage, pancreatic cancer, and other malignant obstructions, such as gallstones, leading to bile duct blockage, are the main drivers of metal stents.
Bilio-pancreatic leakages, pancreatic cancer, benign biliary strictures, gallstones, and other conditions are all treated using biliary stents. In 2021, the gallstones segment generated USD 167.2 million in revenue. The adoption of an unhealthy and sedentary lifestyle, as well as a family history of gallstones, have been identified as some of the major factors contributing to the high occurrence of gallstones. Gallstones are a non-fatal condition of the biliary system that affects millions cheval.
Between 2022 and 2028, ambulatory surgical centres are predicted to grow at a rate of more than 6.8%. With various advantages of ambulatory care, such as reduced costs, faster recovery, and lower infection rates, as well as a growing preference for minimally invasive procedures, the segment is seeing increased demand in developed and developing countries alike. In order to attract a larger client base, boosting the adoption of biliary stents and related treatments requires a low risk of consequences.
KEY MARKET SEGMENTATION
By Product Type
Benign Biliary strictures
By End Users
Ambulatory Surgical Centers
Need any customization research on Pancreatic and Biliary Stents Market - Enquiry Now
North American region accounted for over 37.5 percent of the total world biliary stents market. The regional market size would be driven by an increasing geriatric population prone to ailments including pancreatic cancer, gallstones, and other malignant obstructions. Furthermore, rising awareness of modern technologies for treatment would boost the biliary stents industry projections in North America.
Rest of Europe
Rest of Asia-Pacific
The Middle East & Africa
Rest of Middle East & Africa
Rest of Latin America
Some of the major key players are Boston Scientific Corp, Becton Dickinson and Co, ConMed Corp, Hobbs Medical Inc Medtronic Plc, Olympus Corp, Hellman & Friedman LLC., Cook Group Inc, W. L. Gore & Associates Inc, and other players.
ConMed Corp-Company Financial Analysis
|Market Size in 2022
|US$ xx Million
|Market Size by 2030
|US$ xx Million
|CAGR of 6.8% From 2023 to 2030
|Report Scope & Coverage
|Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook
|• By Product Type (Metal Stents, Plastic Stents)
• By Applications (Bilio-pancreatic leakages, Pancreatic Cancer, Benign Biliary strictures, Others)
• By End Users (Hospitals, Ambulatory Surgical Centers, Speciality Clinics, Others)
|North America (USA, Canada, Mexico), Europe
(Germany, UK, France, Italy, Spain, Netherlands,
Rest of Europe), Asia-Pacific (Japan, South Korea,
China, India, Australia, Rest of Asia-Pacific), The
Middle East & Africa (Israel, UAE, South Africa,
Rest of Middle East & Africa), Latin America (Brazil, Argentina, Rest of Latin America)
|Boston Scientific Corp, Becton Dickinson and Co, ConMed Corp, Hobbs Medical Inc Medtronic Plc, Olympus Corp, Hellman & Friedman LLC. Cook Group Inc, W. L. Gore & Associates Inc, and other players.
|• Prevalence has increased.
• Endosonography and self-expanding metal stents (SEMS) are becoming more well-known.
• The stent industry is boosted by the use of a minimally invasive transpapillary technique.
|• Concerns about the high expense of navigating procedural complexities
• Government Regulations are Strict
Ans: The Pancreatic and Biliary Stents market is to grow at US$ 6.8% over the forecast period 2023-2030.
Boston Scientific Corp, Becton Dickinson and Co, ConMed Corp, Hobbs Medical Inc Medtronic Plc, and, Olympus Corp are the key players in the Pancreatic and Biliary Stents Market.
North America had the largest share of the Pancreatic and Biliary Stents market.
Prevalence has increased, and Endosonography and self-expanding metal stents (SEMS) are becoming more well-known are all propelling the Pancreatic and Biliary Stents market forward.
Concerns about the high expense of navigating procedural complexities, Government Regulations are Strict are the main restraints of the Pancreatic and Biliary Stents market.
Table of Contents
1.1 Market Definition
1.3 Research Assumptions
2. Research Methodology
3. Market Dynamics
4. Impact Analysis
4.1 COVID-19 Impact Analysis
4.2 Impact of Ukraine- Russia war
4.3 Impact of ongoing Recession
4.3.2 Impact on major economies
18.104.22.168 United Kingdom
22.214.171.124 South Korea
126.96.36.199 Rest of the World
5. Value Chain Analysis
6. Porter’s 5 forces model
7. PEST Analysis
8 Pancreatic and Biliary Stents Segmentation, By Product Type
8.1 Metal Stents
8.2 Plastic Stents
9. Pancreatic and Biliary Stents Segmentation, By Applications
9.1 Bilio-pancreatic leakages
9.2 Pancreatic Cancer
9.3 Benign Biliary strictures
10. Pancreatic and Biliary Stents Segmentation, By End Users
10.2 Ambulatory Surgical Centers
10.3 Speciality Clinics
11. Regional Analysis
11.2 North America
11.3.6 The Netherlands
11.3.7 Rest of Europe
11.4.2 South Korea
11.4.6 Rest of Asia-Pacific
11.5 The Middle East & Africa
11.5.3 South Africa
11.6 Latin America
11.6.3 Rest of Latin America
12. Company Profiles
12.1 Boston Scientific Corp
12.1.2 Products/ Services Offered
12.1.3 SWOT Analysis
12.1.4 The SNS view
12.2 Becton Dickinson and Co
12.3 ConMed Corp
12.4 Hobbs Medical Inc Medtronic Plc
12.5 Olympus Corp
12.6 Hellman & Friedman LLC. Cook Group Inc
12.7 W. L. Gore & Associates Inc.
13. Competitive Landscape
13.1 Competitive Benchmark
13.2 Market Share Analysis
13.3 Recent Developments
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
The Cleanroom Technologies Market Size was valued at USD 4.62 billion in 2022 and is expected to reach USD 7.12 billion by 2030 and grow at a CAGR of 5.5% over the forecast period 2023-2030.
In 2022, The Smart Inhalers Market size amounted to USD 13.18 Billion & is estimated to reach USD 53.35 Billion by 2030 and increase at a compound annual growth rate of 19.1% between 2023 and 2030.
The Genomics Services Market size was valued at USD 16.4 billion in 2022 and is estimated to reach USD 46.4 billion in 2030, and grow at a compound annual growth rate approx. CAGR of 12.8% over the forecast period of 2023-2030.
The Infection Surveillance Solutions Market Size was assessed at USD 616.08 million in 2022, and is predicted to increase at a CAGR of 15.2% from 2023 to 2030 and to reach USD 1911 million by 2030.
The Operating Room Integration Market size was estimated USD 1.87 billion in 2022 and is expected to reach USD 4.46 billion by 2030 at a CAGR of 11.5% during the forecast period of 2023-2030.
Microbiome Therapeutics Market size was valued at USD 94.21 million in 2022 and is expected to reach at USD 1403 million by 2030, and grow at a CAGR of 35 % over the forecast period of 2023-2030.
Hi! Click one of our member below to chat on Phone